Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tardive Dyskinesia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00917293
What this trial is testing

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Medicure 53
Large-scale testing (Phase 3)Study completedNCT00672373
What this trial is testing

Extract of Ginkgo Biloba and Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaSchizophrenia
Beijing HuiLongGuan Hospital 157
Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Large-scale testing (Phase 3)Study completedNCT00291213
What this trial is testing

Levetiracetam Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Yale University 50
Large-scale testing (Phase 3)Study completedNCT02198794
What this trial is testing

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 343
Not applicableUnknownNCT02840760
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.

Who this might be right for
Tardive Dyskinesia
Shanghai Mental Health Center 60
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Testing effectiveness (Phase 2)WithdrawnNCT00621634
What this trial is testing

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Université de Montréal
Not applicableStudy completedNCT03497013
What this trial is testing

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Suzhou Psychiatric Hospital 64
Large-scale testing (Phase 3)Study completedNCT02274558
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 234
Testing effectiveness (Phase 2)Study completedNCT01921270
What this trial is testing

Dysport for the Treatment of OMD

Who this might be right for
Oral DystoniaTardive Dystonia
Emory University 18
Testing effectiveness (Phase 2)Study completedNCT01393600
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 37
Large-scale testing (Phase 3)Study completedNCT02291861
What this trial is testing

Addressing Involuntary Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 298
Testing effectiveness (Phase 2)Looking for participantsNCT07365462
What this trial is testing

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 100
Not applicableUnknownNCT06011408
What this trial is testing

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Who this might be right for
Tardive Dyskinesia
iRxReminder 300
Not applicableUnknownNCT01804920
What this trial is testing

D-Serine Treatment For Tardive Dyskinesia

Who this might be right for
Schizophrenia and Schizoaffective DisorderTardive Dyskinesia
Herzog Hospital 16
Not applicableStudy completedNCT01467089
What this trial is testing

The Assessment of Movement Disorders Utilizing Live Two-Way Video

Who this might be right for
Tardive Dyskinesia
Northwell Health 37
Post-approval studies (Phase 4)Study completedNCT03698331
What this trial is testing

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 89
Next Page